Filing Flows

Filing Flows › Neogen (NEOG) › Q2 FY26

Neogen (NEOG) Q2 FY26 earnings results (second quarter fiscal 2026)

10-Q filed Jan 8, 2026

Neogen (NEOG) reported revenue of $225M for the second quarter fiscal 2026 (Q2 FY26), -3% from a year earlier and +7% from the quarter before. Operating margin was -2.4%, net loss $15.9M (7.1% of revenue).

Revenue$225M
Year over year-3%
Quarter over quarter+7%
Operating margin-2.4%
Net earnings−$15.9M

Neogen, Q2 FY26: revenue $225M (-3% year over year), operating margin -2.4%, net loss $15.9M, operating cash flow $19.5M. The chart follows the revenue to costs, profit and cash.

Q2 FY26AmountQ/QY/Y
Revenue$225M+7%-3%
Operating profit−$5.4M——
Net earnings−$15.9M-144%—
Operating cash flow$19.5M+81%-52%
Free cash flow$7.8M—-66%

What changed

Revenue was $224.7M in Q2 FY26, down 3% year over year and up 7% from the previous quarter. Product was the largest line at 89% of revenue. Product lost $8.5M year over year (down 4%), 130% of the total change.

Gross margin was 47.5%, down 1.5 points from a year earlier. Operating costs exceeded revenue by $5.4M, an operating margin of -2.4%. Operating expenses fell 80% while revenue fell 3%. The fastest-growing cost line was General & admin (+13%). The quarter ended with a net loss of $15.9M, after a profit of $36.3M the previous quarter. Net interest and other expense of $15.0M was the main reason.

Operating cash flow was $19.5M (down 52% year over year). Non-cash charges added back $28.9M of depreciation and amortization and $4.3M of share-based compensation. Working capital and other items added $2.2M. Capital expenditures of $11.7M left free cash flow of $7.8M.

Questions

What was Neogen's revenue in the second quarter fiscal 2026?

Neogen (NEOG) reported revenue of $225M for the second quarter fiscal 2026 (Q2 FY26), -3% from a year earlier and +7% from the quarter before.

Was Neogen profitable in the second quarter fiscal 2026?

Operating loss was $5.4M (-2.4% of revenue) and net loss $15.9M.

Open the interactive Sankey →

Source: Neogen 10-Q on SEC EDGAR.